Stay updated on Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a footer note 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:17:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Contacts/Locations and Study Status sections to the study record history, updating the list of locations and the current status. A deletion occurred on 2025-09-05.
    Difference
    0.2%
    Check dated 2025-12-16T03:45:08.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.2, replacing v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T18:21:44.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the banner that stated potential delays due to government funding and NIH operating status from the page; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:59:53.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The record history now shows additional submission versions, expanding the list of past updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T12:38:36.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    8%
    Check dated 2025-10-05T17:37:45.000Z thumbnail image

Stay in the know with updates to Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.